SolasCure demonstrates proof-of-concept in trial of new maggot-derived wound gel

Biotech company SolasCure has announced the results of its proof-of-concept phase 2 trial investigating its wound gel for chronic venous leg ulcer patients.

Related Keywords

,Andy Weymann ,Rob Kirsner ,Aurase Wound Gel ,Bio Developments ,Pipelines ,Emerging Markets ,Wound Healing ,Drug Delivery ,Formulation ,Clinical Trial ,